oral glp-1 agonist approved Semaglutide to Reduce the Risk of Cardiovascular Events Lesson: Oral Semaglutide: A New

Diabetes Care 28 , 10921100 (2005)

What are the side effects

The study appeared in Cancer Investigation on Nov

Dulaglutide was approved in the same year for T2DM but not for weight loss, and although it leads to modest weight reduction, this effect is significantly less than that achieved with semaglutide or liraglutide in obesity-focused trials [2326]

People need to know from the start that these are prescribed as long-term medications for their effect on body weight, glucose levels, and potentially cardiovascular protection, Pratley says, adding that people dont stop antihypertensives or statins because they achieve or reach normal blood pressure or LDL cholesterol levels, respectively